EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico and In Vitro Methods in the Characterization of Beta-Carotene as Pharmaceutical Material via Acetylcholine Esterase Inhibitory Actions

Arunachalam Muthuraman iD, Muthusamy Ramesh, Fazlina Mustaffa iD, Ahmed Nadeem iD, Shamama Nishat, Nallupillai Paramakrishnan, Khian Giap Lim

Molecules · 26.05.2023 · 28 (11) · 4358

DOI: 10.3390/molecules28114358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 26.05.2023. Verfasst von Arunachalam Muthuraman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Unit, Faculty of Pharmacy, AIMST University, Bedong 08100, Malaysia. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malaysian Ministry of Education through the Fundamental Research Grant Scheme,, Malaysian Ministry of Education, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular docking is widely used in the assessment of the therapeutic potential of pharmaceutical agents. The binding properties of beta-carotene (BC) to acetylcholine esterase (AChE) proteins were characterized using the molecular docking method. The mechanism of AChE inhibition was assessed by an experimental in vitro kinetic study. In addition, the role of BC action was tested by the zebrafish embryo toxicity test (ZFET). The results of the docking ability of BC to AChE showed significant ligand binding mode. The kinetic parameter, i.e., the low AICc value shown as the compound was the competitive type of inhibition of AChE. Further, BC also showed mild toxicity at a higher dose (2200 mg/L) in ZFET assessment with changes in biomarkers. The LC50 value of BC is 1811.94 mg/L. Acetylcholine esterase (AChE) plays a pivotal role in the hydrolysis of acetylcholine, which leads to the development of cognitive dysfunction. BC possesses the regulation of acetylcholine esterase (AChE) and acid phosphatase (AP) activity to prevent neurovascular dysfunction. Therefore, the characterization of BC could be used as a pharmaceutical agent for the treatment of cholinergic neurotoxicity-associated neurovascular disorders such as developmental toxicity, vascular dementia, and Alzheimer’s disease due to its AChE and AP inhibitory actions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAlzheimer DiseaseAnimalsAcetylcholinebeta CaroteneMolecular Docking SimulationZebrafishAcetylcholinesterasePharmaceutical Preparations

Stichwörter der Autor:innen

Alzheimer’s diseaseacid phosphatasegalatamineneurovascular disordersrivastigminevascular dementiazebrafish embryo toxicity test

Substanzen

Cholinesterase InhibitorsAcetylcholinebeta CaroteneAcetylcholinesterasePharmaceutical Preparations

Autor:innen und Institutionen

  • Pharmacology Unit, Faculty of Pharmacy, AIMST University, Bedong 08100, Malaysia.
  • Department of Pharmaceutical Analysis, Omega College of Pharmacy, Hyderabad 501301, India.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Comprehensive Cancer Center, Wexner Medical Centre, Ohio State University, Columbus, OH 43210, USA.
  • Department of Pharmacognosy, JSS College of Pharmacy, Mysore, JSS Academy of Higher Education and Research, Mysore 570015, India.

ORCID-Profile: Arunachalam Muthuraman, Fazlina Mustaffa, Ahmed Nadeem

Förderung

  • Malaysian Ministry of Education through the Fundamental Research Grant Scheme,
  • Malaysian Ministry of Education
  • King Saud University

Zitieren

APA

Muthuraman, A., Ramesh, M., Mustaffa, F., Nadeem, A., Nishat, S., Paramakrishnan, N., & Lim, K. G. (2023). In Silico and In Vitro Methods in the Characterization of Beta-Carotene as Pharmaceutical Material via Acetylcholine Esterase Inhibitory Actions. Molecules, 28(11), 4358. https://doi.org/10.3390/molecules28114358

Vancouver

Muthuraman A, Ramesh M, Mustaffa F, Nadeem A, Nishat S, Paramakrishnan N, et al. In Silico and In Vitro Methods in the Characterization of Beta-Carotene as Pharmaceutical Material via Acetylcholine Esterase Inhibitory Actions. Molecules. 2023;28(11):4358. doi:10.3390/molecules28114358

BibTeX
@article{Muthuraman2023,
  author = {Muthuraman, Arunachalam and Ramesh, Muthusamy and Mustaffa, Fazlina and Nadeem, Ahmed and Nishat, Shamama and Paramakrishnan, Nallupillai and Lim, Khian Giap},
  title = {In Silico and In Vitro Methods in the Characterization of Beta-Carotene as Pharmaceutical Material via Acetylcholine Esterase Inhibitory Actions},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {11},
  pages = {4358},
  doi = {10.3390/molecules28114358}
}
Kostenlos starten →